MedTrace Logo

Uterine Artery Ligation to Decrease Blood Loss With Central Placenta Previa

NCT02002026 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 52

Last updated 2016-03-16

No results posted yet for this study

Summary

This trial will address the effect of uterine artery ligation during Cesarean section in cases with placenta previa to decrease blood loss.

Conditions

  • Placenta Previa Without Hemorrhage

Interventions

PROCEDURE

Uterine artery ligation

Uterine artery ligation during cesarean section before delivery of the baby

Sponsors & Collaborators

  • Minia Maternity University Hospital

    lead OTHER

Principal Investigators

  • Ahmad S Sameer, MD · Minia Maternity University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
49 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-11-30
Primary Completion
2014-11-30
Completion
2014-11-30

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02002026 on ClinicalTrials.gov